Literature DB >> 17188080

Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.

Jan Kulig1, Tadeusz Popiela, Piotr Kolodziejczyk, Marek Sierzega, Antoni Szczepanik.   

Abstract

BACKGROUND: A multicenter, randomized, clinical trial was initiated to evaluate the possible benefits of extended D2 (D2+) lymphadenectomy after potentially curative resection of gastric cancer.
METHODS: Standard D2 lymphadenectomy was defined according to the Japanese Gastric Cancer Association classification. D2+ lymph node dissection additionally included the removal of para-aortic nodes.
RESULTS: Of 781 patients screened, 275 were randomized to standard D2 (n = 141) or extended D2+ (n = 134) lymphadenectomy. The overall morbidity rates were comparable in D2 (27.7%; 95% confidence interval [CI], 20.3-35.1) and D2+ (21.6%; 95% CI, 13.7-29.5) groups (P = .248). Pre-existing cardiac disease, splenectomy, and excessive blood loss were identified as risk factors for overall and nonsurgical complications. Postoperative mortality rates were 4.9% (95% CI, 1.4-8.5) and 2.2% (95% CI, 0-4.7), respectively (P = .376).
CONCLUSIONS: The interim safety analysis failed to show any significant difference with regard to the extent of lymph node dissection. The surgical outcome was not different between the 2 surgeries.

Entities:  

Mesh:

Year:  2007        PMID: 17188080     DOI: 10.1016/j.amjsurg.2006.04.018

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  27 in total

Review 1.  Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?

Authors:  Yasuhiro Kodera; Daisuke Kobayashi; Chie Tanaka; Michitaka Fujiwara
Journal:  Surg Today       Date:  2014-11-01       Impact factor: 2.549

2.  Effects of extended lymphadenectomy and postoperative chemotherapy on node-negative gastric cancer.

Authors:  Qiang Xue; Xiao-Na Wang; Jing-Yu Deng; Ru-Peng Zhang; Han Liang
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

3.  Effect of lymphadenectomy extent on advanced gastric cancer located in the cardia and fundus.

Authors:  Chang-Ming Huang; Bi-Juan Lin; Hui-Shan Lu; Xiang-Fu Zhang; Ping Li; Jian-Wei Xie
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

4.  Reoperation for early postoperative complications after gastric cancer surgery in a Chinese hospital.

Authors:  Birendra Kumar Sah; Ming-Min Chen; Min Yan; Zheng-Gang Zhu
Journal:  World J Gastroenterol       Date:  2010-01-07       Impact factor: 5.742

Review 5.  Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer.

Authors:  Zhen Wang; Jun-Qiang Chen; Yun-Fei Cao
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 6.  Lymphadenectomy in gastric cancer: Contentious issues.

Authors:  Pankaj Kumar Garg; Ashish Jakhetiya; Jyoti Sharma; Mukur Dipi Ray; Durgatosh Pandey
Journal:  World J Gastrointest Surg       Date:  2016-04-27

7.  Early postoperative anastomotic hemorrhage after gastrectomy for gastric cancer.

Authors:  Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Tokunaga; Hiroyuki Ono; Masanori Terashima
Journal:  Gastric Cancer       Date:  2010-04-07       Impact factor: 7.370

Review 8.  Lymph node dissection in the resection of gastric cancer: review of existing evidence.

Authors:  Yutaka Tanizawa; Masanori Terashima
Journal:  Gastric Cancer       Date:  2010-09-05       Impact factor: 7.370

9.  D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery.

Authors:  Jian-Kun Hu; Kun Yang; Bo Zhang; Xin-Zu Chen; Zhi-Xin Chen; Jia-Ping Chen
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

Review 10.  Advanced gastric cancer: What we know and what we still have to learn.

Authors:  Federico Coccolini; Giulia Montori; Marco Ceresoli; Simona Cima; Maria Carla Valli; Gabriela E Nita; Arianna Heyer; Fausto Catena; Luca Ansaloni
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.